Cadre Holdings, Inc.·4

Jun 18, 4:19 PM ET

Norton Hamish 4

4 · Cadre Holdings, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Cadre Holdings (CDRE) Director Hamish Norton Receives Option Grant

What Happened
Hamish Norton, a director of Cadre Holdings, was granted a derivative award (stock options) for 17,393 shares on June 16, 2026. The reported acquisition price is $0.00 (this is an option/award, not a cash purchase or sale), so no cash changed hands at grant.

Key Details

  • Transaction date: 2026-06-16; Form 4 filed 2026-06-18 (filed within the standard two-business-day window).
  • Transaction type/code: A (award/grant); derivative option covering 17,393 shares @ $0.00.
  • Vesting schedule (from footnote): 4,349 options vest on June 30, 2026; and 4,348 options vest on each of Sep 30, 2026, Dec 31, 2026, and Mar 31, 2027.
  • Shares owned after transaction: not specified in the provided filing details.
  • Plan: Granted under the Issuer’s 2021 Stock Incentive Plan.
  • No immediate sale or cashless exercise reported.

Context
This is a standard director option grant — a compensation/retention award rather than an open-market buy or sale. For retail investors, such grants do not necessarily signal insider buying conviction because they are commonly part of director compensation and vest over time. Since these are options, value to the insider depends on future stock performance and any exercise price (not detailed beyond the $0 reported for the grant entry).

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Stock Option (right to purchase)

    [F1]
    2026-06-16+17,39317,393 total
    Exercise: $28.75Exp: 2036-06-16Common Stock (17,393 underlying)
Footnotes (1)
  • [F1]The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
Signature
/s/ Hamish Norton|2026-06-18

Documents

1 file
  • 4
    tm2618182-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT